We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

1 hedge funds and large institutions have $4.52M invested in Seelos Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

56% less call options, than puts

Call options by funds: $253K | Put options by funds: $572K

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$253K
Puts
$572K
Net Calls
-$319K
Net Calls Change
-$319K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.04M +$3.11M +1 New
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$607K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$464K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$296K – – –
NSIM
5
North Star Investment Management
Illinois
$240K – – –
BFA
6
BlackRock Fund Advisors
California
$219K – – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$141K – – –
Northern Trust
8
Northern Trust
Illinois
$103K – – –
U
9
UBS
Switzerland
$95K – – –
RG
10
Rathbones Group
United Kingdom
$82K – – –
RCM
11
Rotella Capital Management
Washington
$49K – – –
Nomura Holdings
12
Nomura Holdings
Japan
$44K – – –
Deutsche Bank
13
Deutsche Bank
Germany
$39K – – –
GC
14
Guggenheim Capital
Illinois
$29K – – –
State Street
15
State Street
Massachusetts
$27K – – –
BA
16
BlackRock Advisors
Delaware
$17K – – –
AIG
17
American International Group
New York
$13.2K – – –
Citigroup
18
Citigroup
New York
$6K – – –
Citadel Advisors
19
Citadel Advisors
Florida
$4K – – –
Bank of America
20
Bank of America
North Carolina
$2K – – –
HDIM
21
Hanson & Doremus Investment Management
Vermont
$2K – – –
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
HI
23
Hudock Inc
Pennsylvania
$1K – – –
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$1K – – –

SEEL Hedge Fund Activity: Q2 2013 in Review

1 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q2 2013, worth a combined $4.52M.

Buyers outnumbered sellers: 1 fund opened new SEEL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $4.52M of Seelos Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 1 fund opened new Seelos Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2013.